Skip to main content
. 2022 May 27;12:785350. doi: 10.3389/fonc.2022.785350

Table 2.

Median OS from SBRT in months as calculated from the end of radiation treatment.

Immunotherapy Median OS from SBRT (months) p-value
Before* 3.285 0.014
Concurrent/After* 13.010
Before/Concurrent 8.181 0.33
After 12.682
Concurrent 13.010 0.46
Before/After 8.641

*Indicates significance. OS, Overall Survival; SBRT, Stereotactic Body Radiotherapy.